ABVC
ABVC BIOPHARMA, INC.Company Information
- Company Name
- ABVC BIOPHARMA, INC.
- CIK
- CIK0001173313
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- ABVC: Nasdaq, ECOC: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ABVC
SEC filing data through
Insider Sentiment
- Last purchase
- 2010-05-11
- Last sale
- 2009-01-23
- Shares purchased (TTM)
- 916,709
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 816,526
- Shares outstanding
- 25,448,516
- Ownership
- 3.21%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- 0.00%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Related Party | -0 | 0 | 1 | 1 | -0 | 1 | 1 | 0 | -0 | 0 | 0 | 1 | ||||||
| Third Parties | 0 | 1 | - | - | - | - | - | - | - | - | - | - | ||||||
Assets Current | ||||||||||||||||||
| Cash | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Restricted Cash | - | - | - | - | - | - | - | - | - | 1 | 1 | 1 | ||||||
| Restricted Cash Current | - | - | 1 | 20 | 20 | 1 | 1 | 1 | 1 | - | 20 | - | ||||||
| Accounts Receivable Net Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | - | - | - | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Other Receivables Net Current | - | - | - | - | 1 | - | - | - | - | - | - | - | ||||||
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 0 | 1 | 3 | 3 | 3 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Property Plant And Equipment Net | 13 | 13 | 13 | 13 | 8 | 8 | 1 | 1 | 8 | 8 | 1 | 8 | ||||||
| Operating Lease Right Of Use Asset | 2 | 2 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Long Term Investments | 2 | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | ||||||
| Deferred Income Tax Assets Net | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Prepaid Expense Noncurrent | 1 | 2 | 1 | 1 | - | - | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Security Deposit | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Assets | 19 | 20 | 21 | 21 | 16 | 15 | 8 | 8 | 8 | 8 | 8 | 17 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Other Receivable After Allowance For Credit Loss Noncurrent | - | - | - | - | - | - | 4 | - | - | 0 | 0 | - | ||||||
Liabilities Current | ||||||||||||||||||
| Short Term Borrowings | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | - | ||||||
| Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | - | 4 | 4 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Current | - | - | - | - | 1 | - | - | 0 | 0 | - | 0 | - | ||||||
| Convertible Notes Payable Current | - | - | - | - | 0 | - | - | - | 1 | 1 | 1 | - | ||||||
| Taxes Payable Current | - | 0 | 0 | 0 | 0 | - | - | - | - | 0 | 0 | - | ||||||
| Liabilities Current | 6 | 5 | 6 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 | 5 | ||||||
| Security Deposit Liability | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 1 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Convertible Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | - | 2 | ||||||
| Liabilities | 7 | 7 | 8 | 7 | 7 | 7 | 7 | 6 | 7 | 7 | 7 | 8 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 98 | 97 | 96 | 94 | 86 | 84 | 79 | 78 | 87 | 86 | 74 | 81 | ||||||
| Stockholders Equity Note Subscriptions Receivable | - | - | - | - | - | - | - | - | - | -0 | -0 | -1 | ||||||
| Retained Earnings Accumulated Deficit | -79 | -78 | -77 | -74 | -72 | -70 | -69 | -71 | -70 | -69 | -64 | -62 | ||||||
| Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | - | ||||||
| Treasury Stock Value | -9 | -9 | -9 | -9 | -9 | -9 | -9 | -9 | -9 | -9 | -9 | -9 | ||||||
| Stockholders Equity | 12 | 11 | 11 | 12 | 7 | 8 | 1 | 1 | 2 | 2 | 2 | 9 | ||||||
| Minority Interest | 2 | 2 | 2 | 2 | 2 | 3 | -1 | -0 | -0 | -0 | -0 | -0 | ||||||
| Liabilities And Stockholders Equity | 19 | 20 | 21 | 21 | 16 | 15 | 8 | 8 | 8 | 8 | 8 | 17 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 10 | ||||||
| Common Stock Shares Issued | 26 | 26 | 25 | 24 | 20 | 15 | 14 | 13 | 12 | 2 | 8 | 5 | ||||||
| Shares Outstanding | 26 | 26 | 25 | 24 | 20 | 15 | 14 | 13 | 12 | 11 | 8 | 5 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialABVC BIOPHARMA, INC. (ABVC) — SEC Financial Statements & Analysis
ABVC BIOPHARMA, INC. (ABVC) is a pharmaceutical preparations company, incorporated in NV. ABVC BIOPHARMA, INC. trades on Nasdaq, OTC as: ABVC, ECOC. ABVC BIOPHARMA, INC. (ABVC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, ABVC BIOPHARMA, INC. carries a market cap of $41.17M, a P/E ratio of -5.83x, a P/B ratio of 3.36x, a P/S ratio of 1295.61x, an enterprise value of $41.20M, and an EV/EBITDA multiple of -6.35x. On profitability, it posts a gross margin of 99.85%, an operating margin of -20501.81%, a net margin of -22210.90%, a Return on Equity (ROE) of -73.21%, a Return on Assets (ROA) of -39.61%, and a Return on Invested Capital (ROIC) of -67.27%. Per share, it reports EPS of $-0.27, diluted EPS of $-0.27, free cash flow per share of $-0.10, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -93.75% year-over-year, net income growth of 50.52% year-over-year, and EPS growth of 0.43% year-over-year. On the balance sheet, it maintains a current ratio of 0.07x, a quick ratio of 0.05x, working capital of $-5.28M, a debt-to-equity ratio of 0.58x, a debt ratio of 0.37, an interest coverage ratio of -41.98x, free cash flow of $-2.69M (TTM), and net debt of $27.52K. Figures sourced from SEC EDGAR.
- Market Cap
- $41.17M
- P/E TTM
- -5.83x
- EPS TTM
- $-0.27
- P/B TTM
- 3.36x
- ROE TTM
- -73.21%
- ROA TTM
- -39.61%
- Debt To Equity
- 0.58x
- Free Cash Flow TTM
- $-2.69M
- Net Revenue TTM Growth 1Y
- -93.75%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ABVC BIOPHARMA, INC. in?
ABVC BIOPHARMA, INC. (ABVC) operates in the Pharmaceutical Preparations industry.
What exchange does ABVC trade on?
ABVC BIOPHARMA, INC. (ABVC) trades on the Nasdaq, OTC.
Where is ABVC BIOPHARMA, INC. incorporated?
ABVC BIOPHARMA, INC. is incorporated in NV.
When was ABVC BIOPHARMA, INC. (ABVC)'s most recent SEC filing?
ABVC BIOPHARMA, INC. (ABVC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is ABVC's market cap?
ABVC BIOPHARMA, INC. (ABVC) has a market capitalization of $41.17M as of 2026-06-30.
What is ABVC's EPS (earnings per share)?
ABVC BIOPHARMA, INC. (ABVC)'s trailing twelve month EPS is $-0.27 as of 2026-06-30.
What is ABVC's ROE (return on equity)?
ABVC BIOPHARMA, INC. (ABVC)'s trailing twelve month Return on Equity (ROE) is -73.21% as of 2026-06-30.
What is ABVC's ROA (return on assets)?
ABVC BIOPHARMA, INC. (ABVC)'s trailing twelve month Return on Assets (ROA) is -39.61% as of 2026-06-30.
What is ABVC's ROIC (return on invested capital)?
ABVC BIOPHARMA, INC. (ABVC)'s trailing twelve month Return on Invested Capital (ROIC) is -67.27% as of 2026-06-30.
What is ABVC's EV/EBITDA?
ABVC BIOPHARMA, INC. (ABVC)'s trailing twelve month EV/EBITDA is -6.35x as of 2026-06-30.